Orphan designation: Pegylated recombinant human hyaluronidase PH20(pegvorhyaluronidase alfa), Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-bf8d49 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Orphan Designation ◽

Recombinant Human Hyaluronidase

Download Full-text

Orphan designation: Pegylated recombinant human hyaluronidase PH20(pegvorhyaluronidase alfa), Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-beb832 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Orphan Designation ◽

Recombinant Human Hyaluronidase

Download Full-text

Orphan designation: Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1, Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-2b1b7f2 ◽

2020 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Monoclonal Antibody ◽

Mucin 1 ◽

Orphan Designation ◽

Humanized Monoclonal Antibody

Download Full-text

Orphan designation: Relacorilant, Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-26d9aea ◽

2020 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Orphan Designation

Download Full-text

Orphan designation: Nanoliposomal irinotecan, Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-6ac70a ◽

2018 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Orphan Designation ◽

Nanoliposomal Irinotecan

Download Full-text

Orphan designation: autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand, The treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-bc1102 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Tumour Necrosis Factor ◽

Stromal Cells ◽

Tumour Necrosis ◽

Genetically Modified ◽

Orphan Designation ◽

Necrosis Factor

Download Full-text

Orphan designation: Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin, Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-26af3b4 ◽

2020 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Listeria Monocytogenes ◽

Orphan Designation

Download Full-text

Orphan designation: Nanoliposomal irinotecan, Treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-679576 ◽

2018 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Orphan Designation ◽

Nanoliposomal Irinotecan

Download Full-text

PO-298 Pegylated recombinant human hyaluronidase PH20 (PEGPH20) increases tumour uptake and efficacy of cetuximab in a human pancreatic cancer xenograft model

10.1136/esmoopen-2018-eacr25.811 ◽

2018 ◽

Author(s):

J Souratha ◽

R Osgood ◽

J Cowell ◽

A Fathallah ◽

C Thompson ◽

...

Keyword(s):

Pancreatic Cancer ◽

Xenograft Model ◽

Human Pancreatic Cancer ◽

Tumour Uptake ◽

Recombinant Human Hyaluronidase

Download Full-text

Orphan designation: autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand, The treatment of pancreatic cancer

Case Medical Research ◽

10.31525/cmr-bc6b49 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Tumour Necrosis Factor ◽

Stromal Cells ◽

Tumour Necrosis ◽

Genetically Modified ◽

Orphan Designation ◽

Necrosis Factor

Download Full-text

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-2010 ◽

2016 ◽

Vol 22 (12) ◽

pp. 2848-2854 ◽

Cited By ~ 182

Author(s):

Sunil R. Hingorani ◽

William P. Harris ◽

J. Thaddeus Beck ◽

Boris A. Berdov ◽

Stephanie A. Wagner ◽

...

Keyword(s):

Pancreatic Cancer ◽

Advanced Pancreatic Cancer ◽

Phase Ib ◽

Recombinant Human Hyaluronidase

Download Full-text